Oxyzo Financial Services Limited, the lending arm of OfBusiness, has secured Rs 100 crore through non-convertible debentures (NCDs) to strengthen its financing business. The investment, made through AK Capital Finance Limited, was finalized on February 18, 2025, as per regulatory filings. The funding reflects Oxyzo’s commitment to supporting businesses with supply chain financing while positioning itself for future growth.

Oxyzo Strengthens Its Supply Chain

The raised funds come from the issuance of 1,00,000 NCDs, each priced at Rs 10,000, with a maturity period of two years ending on February 18, 2027. The bonds carry an annual interest rate of 9.75% and are secured by collateral valued at 110% of the outstanding principal amount. This structured debt issuance aligns with Oxyzo’s focus on supply chain financing, providing businesses with necessary working capital to manage their financial operations efficiently.

Oxyzo has grown significantly since its inception, transitioning from a private company to a public limited entity. The company specializes in structured credit solutions, offering tailored financing options to businesses. With this latest capital infusion, Oxyzo continues to expand its lending capabilities and strengthen its market presence.

OfBusiness Eyes $500 Million IPO

Oxyzo’s parent company, OfBusiness, has been making strategic moves to enter the public markets. Reports suggest that the SoftBank-backed B2B unicorn is in discussions with investment bankers, including Kotak Investment Banking, to launch an initial public offering (IPO) worth $500 million. The IPO is expected to take place by August 2026 and will include both primary and secondary share offerings.

Oxyzo, in which OfBusiness holds a majority stake of over 70%, is also considering a public listing in the future. While no official timeline has been announced, the company is exploring options to position itself as an independent entity in the financial services sector.

Oxyzo and OfBusiness: A Profitable Growth Story

Founded in 2015, OfBusiness has emerged as one of India’s most successful unicorns, consistently delivering strong financial results. In FY23, the company reported a net profit of Rs 463.3 crore, with revenues doubling to Rs 15,300 crore.

Oxyzo, which became a unicorn in 2022, has also experienced rapid growth. The company recorded a profit of Rs 200 crore on a revenue of Rs 570 crore in FY23. As Oxyzo continues to scale, its expertise in supply chain financing is expected to drive further expansion in the financial sector.

With its latest secured NCD issuance, Oxyzo is set to enhance its lending operations and support more businesses with financial solutions. Meanwhile, OfBusiness is actively preparing for its IPO, which could unlock significant growth opportunities. As both companies continue their upward trajectory, investors and stakeholders are closely watching their next moves in the financial and corporate landscape.